Understanding a patients full metabolic risk profile including insulin sensitivity, inflammatory markers, hormonal status, and body composition enables our physicians to develop a genuinely personalised strategy for disease prevention, of which GLP-1 therapy may form an important component
The constant, however, is this: we can only apply the right protocol if we know youre on the medication
Manufacturer contact THG POLAND HARDERWEG 2 22549 HAMBURG Germany WWW.PERRICONEMD.COM
These medications are administered via subcutaneous injection and are not absorbed through the gastrointestinal tract, meaning dietary components do not affect their bioavailability or metabolism in the way they might with oral medications
Se unen a los receptores de GLP-1, activando las mismas vas que regulan el apetito, la digestin y la respuesta a la insulina con mayor consistencia